INTRODUCTION
Every sensorineural structure, when submitted to a stimulus, emits bioelectrical potentials as response. thus, the acoustic stimulation of the human auditory receptor triggers a number of electrical responses, or evoked potentials, which result in the successive activation of the cochlea and the neurons which make up the auditory pathway. 1 the technical capacity to record electrical potentials in different levels of the nervous system in response to acoustic stimulation has produced a large number of relevant applications to otolaryngologists, audiologists and neurologists. these potentials may be recorded by non-invasive techniques, without bringing discomfort to the patient, and often without the need for sedation or anesthesia, which has increased its clinical applicability. 2 auditory Evoked Potentials (aEP) enable the assessment of the auditory pathway functional integrity, from the peripheral receptor organ, all the way to the cerebral cortex.
there are many expressions found in the literature, such as Brain stem audiometry -BEra (Brainstem Evoked responses audiometry), very much used in Brazil, and also the less proper expressions and which are farther apart from its properties.
aBr (audiometry Brainstem responses) is based on the recording and analysis of the electrophysiological activity of the peripheral auditory system all the way to the brain stem. these are early auditory evoked potentials, because the responses arise in the first 12 milliseconds (ms) after sound stimuli and it is made up of a seven wave polyphasic potential. 2 Waves i, iii and V are the most prominent, and for this reason these are the waves considered in the analysis of the plotted graph. the parameters assessed are: the very presence of the waves, replication or reproducibility, absolute latency, latency interval between waves (interpeak intervals), interaural latency difference, sound intensity, latency and amplitude. 3 aEPs, besides enabling one to investigate the individual's peripheral hearing, they also help assess the central auditory pathway integrity, its maintenance during the development process and dysfunctions caused by many diseases. 4 aBr's clinical applications can be divided into neurologic and audiologic, with the main goal of identifying abnormalities in the auditory nerve and the brain stem, and estimate the electrophysiological auditory threshold, based on the presence of responses to different levels of stimulus intensity. in the literature we find papers that use aBr as an auditory screening test for high risk newborns. 5, 6 it is also used for intraoperative monitoring during ponscerebellar angle surgery. 7 one of the most studied applications of this type of test is to diagnose vestibular nerve schwannomas 3 ; however, there are controversies regarding the test's sensitivity and specificity. 8 today, aBr is very important in otoneurological assessments, and it is used by many medical specialties because of its high sensitivity, speed, objectivity and also because it enables one to follow disease progression and that of treatment.
our goal with the present investigation is to analyze and compare aBr traces in regards to: gender distribution; test applicability to the different age ranges; risk factors correlation in newborns up to one year of age and test alterations; incidence of conductive/cochlear alterations; retrocochlear alterations; increase in wave absolute latency and interpeak interval alterations, including a differential study of these parameters in so far as gender is concerned.
MATERIALS AND METHODS
We carried out a retrospective study, properly approved by the Ethics in research Committee (CEP) of the faculdade de Medicina de Jundiaí (fMJ) -sP, in a population of 403 patients who were referred to us by pediatricians, neuro-pediatricians, neurologists, neurosurgeons and otorhinolaryngologists, with doubts regarding their hearing and/or alterations in the central auditory pathways (retrocochlear), submitted to the brainstem audiometry test (aBr) in a private clinic of Jundiaí, in the state of são Paulo. the tests were carried out from June of 1998 to May of 2005 and sequentially analyzed, not excluding any chart. We used a gsi®-55 aBr screener device, at 2000 clicks per minute, lasting 100μs (encompassing the frequencies from 2000 to 4000hz), with one channel insertion phones and a 12 millisecond window. the sample was initially broken down by gender. the patients were broken down by age range (less than one year, between one year and less than 6 years, between 6 years and less than 12 years, between twelve years and less than 20 years, between 20 years and less than forty years, between forty years and less than 70 years, and finally, those with more than 70 years of age. as far as applicability is concerned, the tests were plotted in accordance to their end or indication (hearing threshold, retrocochlear assessment or both). as conductive and/or cochlear alterations we considered: absolute latency increase of all the waves without interpeak interval alterations and a lowering of the minimum response level. as for retrocochlear alteration, we considered an increase in wave absolute latency time and/or wave amplitude alteration. following that, we assessed: the distribution of conductive/cochlear and retrocochlear findings, in agreement with gender and age range, absolute latencies associated with gender and the incidence of alterations in interpeak intervals. in children younger than twelve years of age and in the presence of risk factors we analyzed the incidence of conductive, cochlear and retrocochlear alterations, in accordance with the aforementioned criteria. the neonatal risk factors considered in our paper were the same ones described in the 2000 consensus from the "Joint Committee on infant hearing" 9 (which include the american academies of audiology, otolaryngology and head and neck surgery, Pediatrics, speech, language and hearing and the Education Council for the hearing impaired), to say: 1) less than 1500 grams of birth weight or preterm less than 34 weeks;
2) newborn small for the gestational age; 3) severe Perinatal asphyxia; 4) intracranial hemorrhage or leucoencephalomalacia; 5) suspected or confirmed congenital infection; 6) bacterial meningitis and/or septicemia; 7) use of ototoxic drugs; 8) hyperbilirubinemia; 9) family history of hearing loss; 10) parents who are related; 11) syndromes associated with hearing loss; 12) head and neck malformations; 13) newborns who required neonatal iCu for 48 hours or more. all the data collected was stored in a database created in access® and was later on analyzed and plotted in tables and charts. 
RESULTS

DISCUSSION
Within the analyzed period, we carried out brain stem audiometry (aBr) in 403 patients, with a predominance of males (57% -table 1 and graph 1).
as far as age is concerned, we observed two peaks of incidence: 1) age range between 1 and 6 years, having seen that in the pediatric population, classic tonal audiometry is more properly carried out within the mental ages of 5 and 7 years, and that is why we preferred the electrophysiological test;
2) age range between 40 and 70 years, since in it aBr is frequently used for the topodiagnosis of hearing loss or hearing complaints10 (table 2 and graph 2). such fact is reinforced by table 3 and graph 3 which show a proper indication of aBr orders, in other words, in the pediatric range until 6 years, aBr prevailed in order to assess the auditory threshold in relation to the brain stem evaluation, while in adults the opposite happened. in the general distribution, 5% (19) of the tests were ordered with the aim of checking the auditory threshold, 40% (163) for stem assessment and 55% (221) for both.
By analyzing the tables and graphs 4 and 5, we noticed an incidence of conductive or cochlear alterations of 44.5% in females and of 46% in males, while the incidence of retrocochlear findings was of 17.9% in females and of 21.3% in males, the latter was statistically significant (p>0.05-tables and graphs 6 and 7).
By analyzing the conductive or cochlear alterations by age range, we noticed a higher incidence in the age range of 70 years with a rate of 0.80 (very likely because of a hearing loss associated with aging and degenerative alterations) 11 . the general index was 0.45 (table 8 and  graph 8) .
as far as retrocochlear alterations are concerned we see a higher incidence in the age range between 12 and 20 years (n = 14), with an index of 0.36; and a general index of 0.20 (table 9 and graph 9) , and when we analyze those F  130  10  33  136  5  32  133  9  31  173   M  178  17  35  182  15  33  182  13  35  230   Total  308  27  68  318  20  65  315  22  66  403 children below one year of age (n= 58) the incidence of conductive/cochlear and retrocochlear alterations, even with the risk factors reported in the Method, we noticed indices of 0.33 and 0.22 respectively. these values are near and one of them is even lower than the one found in the general sample (n = 403), which were 0.45 and 0.20 respectively. thus, we noticed that children with risk factors did not show a higher incidence of conductive, cochlear or retrocochlear alterations when compared to the general population studied. in relation to the absolute latencies of waves i, iii and V, we observed a difference between the genders, and they were higher among males, and this is in agreement with literature reports 12 (table 10 and graph 10). in relation to interpeak interval alterations (n = 69), we noticed that there were no differences between the genders, and the i-iii interval was the one that presented the higher rate of alterations (39%)(graph 11). although the incidence of alterations in the interpeak intervals is higher for men (table 11 and graph 12), we highlight the greater incidence in males (230 men: 173 women studied) and small percentage differences. according to the literature, gender and age, the frequency of the stimulus and click phase impact on the absolute latencies, being however, controversial the influence of these factors in interpeak intervals 12 .
Graph 3.
Reason for ordering the test (ABR), broken down by age range (n = 403).
Graph 4.
Incidence of female patients with conductive or cochlear alterations (index of 0.445 or 44.5%).
Graph 5.
Incidence of male patients with conductive or cochlear alterations (index of 0.46 or 46%).
